<DOC>
	<DOCNO>NCT01628328</DOCNO>
	<brief_summary>This study aim examine hypothesis tumor cell dissemination colonic stenting obstruct colorectal cancer measure level plasma circulate tumor cell procedure successful colonic stenting patient .</brief_summary>
	<brief_title>Colonic Stent Tumor Cell Dissemination</brief_title>
	<detailed_description>1 . Patient recruitment : Patients recruit Division Colorectal Surgery , Department Surgery , University Hong Kong , 12 - 18 month period . Our institution tertiary referral center colorectal cancer patient Hong Kong . Informed consent obtain patient inclusion criterion meet . The study plan recruit 25 patient colonic stenting group compare 15 patient control group . Inclusion criterion : Colonic stenting group 1 . Patients obstructive colorectal cancer require colonic stenting treatment 2 . Age &gt; 18 year able give inform consent 3 . Informed consent blood collection obtain Control group 1 . Patients colorectal cancer colonoscopy without stenting 2 . Age &gt; 18 year able give inform consent 3 . Informed consent blood collection obtain 2 . Blood collection examination circulate tumor cell About 10ml EDTA blood collect examination procedure ( colonoscopic stenting colonoscopy control group ) blood collection daily repeat 3 day procedure . Blood send laboratory processing within 2 hour withdrawal . Circulating tumour cell , characterize CD45- ( exclude hematopoietic cell ) , CD326+ ( mark epithelial cell ) , CK18+ CK19+ ( mark intestinal cell ) , i.e . cell express CD45-CD326+CK18/19+ , detect fluorescence activate cell sort ( FACS ) . For ml blood , 1 ml FCM Lysing solution add allow incubate 5 minute lyse red blood cell , follow centrifugation 1000 RPM 5 minute . Supernatant aspirate , pellet resuspend approximately 1 ml cold 1X PBS . 10 Âµl appropriate antibody add tube , vortexed incubate 15 dark room temperature . After incubation , cell wash PBS incubate second antibody . The process repeat 4 antibody label cell . Cells analyse FACS machine ( MoFlo , Beckman Coulter ) .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<criteria>Colonic stenting group 1 . Patients obstructive colorectal cancer require colonic stenting treatment 2 . Age &gt; 18 year able give inform consent 3 . Informed consent blood collection obtain Control group 1 . Patients colorectal cancer colonoscopy without stenting 2 . Age &gt; 18 year able give inform consent 3 . Informed consent blood collection obtain Patients refuse unable give inform consent blood take study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>colonic stenting</keyword>
	<keyword>colorectal cancer obstruction</keyword>
	<keyword>circulate tumor cell</keyword>
</DOC>